With an expanding armamentarium of phosphate-lowering therapies available to treat hyperphosphatemia in patients with chronic kidney disease (CKD), an understanding of their differentiating factors and latest clinical evidence is essential for individualizing therapy and improving patient outcomes. In this interactive Booster Quiz, test your knowledge of the key differences between phosphate-lowering therapies and examine up-to-date efficacy and safety data guiding their use. Don’t miss the opportunity to: Test your knowledge of the latest clinical evidence for managing hyperphosphatemia in CKD Get instant feedback on your answer selections See how well you do relative to other healthcare professionals Access downloadable evidence and relevant clinical practice tips.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/managing-hyperphosphatemia-associated-chronic-kidney-disease-emerging-data
- Start Date: 2024-12-31 06:00:00
- End Date: 2024-12-31 06:00:00
- Credit Details: AAPA Category 1 Credit™️: 0.25 hours
AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours
Pharmacy: 0.25 hours - Commercial Support: Source: Ardelyx - Amount: 45000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all